COMP <GO>
ADUS vs UNH // 10Y YIELD & FRED MACRO BETA
Addus HomeCare Corporation (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: ADUS 6
— UNH 7
■ METRIC PARITY
LAST: $124.34 (+1.77%) • MKT CAP: $2.32B
macro-sensitivity
—
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADUS VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ADUS | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | 88.57% | -56.07 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.10% | 11.47% | -2.37 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.8x | 16.4x | +0.35 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 4.47% | 6.48% | -2.01 | UNH | /fcf-yield <GO> |
| Operating Margin | 9.70% | 4.82% | +4.88 | ADUS | /operating-margins <GO> |
| Net Profit Margin | 6.70% | 3.14% | +3.56 | ADUS | /net-margins <GO> |
| Revenue Growth (YoY) | 23.20% | 6.46% | +16.74 | ADUS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 3.12 | +2.71 | ADUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | ADUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.1 | 59.2 | +13.91 | ADUS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.3x | 17.1x | +3.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.32B | $368.83B | -$366.51B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ADUS REV | UNH REV | ADUS GROSS % | UNH GROSS % | ADUS FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.42B | $447.57B | 32.5% | 88.7% | $103.8M | $16.07B |
| FY 2024 | $1.15B | $400.28B | 32.5% | 88.3% | $110.4M | $20.70B |
| FY 2023 | $1.06B | $371.62B | — | 89.6% | $112.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADUS // BETA —
UNH // BETA 0.33